Recce advances anti-infective gel to Phase III trial for diabetic foot infections in Australia

Recce advances anti-infective gel to Phase III trial for diabetic foot infections in Australia

New diabetic foot infection treatment could reach Morocco under regional deal

New diabetic foot infection treatment could reach Morocco under regional deal

Recce signs major MENA 10-year licensing deal

Recce signs major MENA 10-year licensing deal

ASX healthcare innovators target costly surgical complications and repeat procedures

ASX healthcare innovators target costly surgical complications and repeat procedures

Recce clears regulatory inspection for Phase III DFI trial in Indonesia

Recce clears regulatory inspection for Phase III DFI trial in Indonesia

No more tears as Recce takes on antibiotic superbug crisis

No more tears as Recce takes on antibiotic superbug crisis

Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight

Inside Biotech: Recce Pharmaceuticals advances late-stage push in antibiotic resistance fight

Biocurious: US military enlists Aussie biotechs in the germ warfare battle

Biocurious: US military enlists Aussie biotechs in the germ warfare battle

Recce lands Brazil patent as global anti-infectives footprint expands

Recce lands Brazil patent as global anti-infectives footprint expands

The world is running out of antibiotics. New research could make old ones work again

The world is running out of antibiotics. New research could make old ones work again